Related Experiment Video
Updated: Jun 12, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
Lignans inhibit cell growth via regulation of Wnt/beta-catenin signaling
Ji-Hye Yoo1, Hee Ju Lee, Kyungsu Kang
1Natural Products Research Center, Korea Institute of Science and Technology, Gangneung, Gangwon-do 210-340, Republic of Korea.
Abstract:
As aberrant activation of Wnt/beta-catenin signaling is one of the major mechanisms of carcinogenesis in colon cancer, identification of inhibitors of this pathway may aid in colon cancer prevention. We investigated the ability of the lignans arctiin, matairesinol and arctigenin from Saussurea salicifolia to inhibit Wnt/beta-catenin signaling in SW480 human colon cancer cells. The lignans inhibited SW480 cell growth. In addition, the transcriptional activity of a reporter construct containing the TCF binding element (TBE) was decreased after the treatment with all three lignans. Although arctiin, matairesinol and arctigenin have similar structures, arctigenin affected Wnt/beta-catenin signaling most significantly. Further, arctigenin reduced the level of beta-catenin by inducing its phosphorylation and thus its degradation. Arctigenin also decreased expression of the beta-catenin/TCF downstream genes CCND1, survivin and CTNNB1, and induced apoptosis. These results suggest that arctigenin, an aglycone with a methoxyl group, potently inhibits the growth of human colon cancer cells via the Wnt/beta-catenin signaling pathway.
Insights
Arctigenin, a lignan from Saussurea salicifolia, effectively inhibits colon cancer cell growth by blocking the Wnt/beta-catenin signaling pathway. This compound reduces beta-catenin levels and induces apoptosis, offering potential for colon cancer prevention.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- Aberrant Wnt/beta-catenin signaling is a key driver of colon cancer development.
- Targeting this pathway is a promising strategy for colon cancer prevention and treatment.
Purpose of the Study:
- To investigate the potential of lignans from Saussurea salicifolia, specifically arctiin, matairesinol, and arctigenin, to inhibit Wnt/beta-catenin signaling in human colon cancer cells.
- To determine which lignan exhibits the most significant inhibitory effect on this pathway.
Main Methods:
- Treatment of SW480 human colon cancer cells with arctiin, matairesinol, and arctigenin.
- Assessment of cell growth inhibition.
- Measurement of transcriptional activity using a TCF binding element (TBE) reporter construct.
- Analysis of beta-catenin levels, phosphorylation, and degradation.
- Evaluation of downstream gene expression (CCND1, survivin, CTNNB1) and apoptosis induction.
Main Results:
- All three lignans inhibited SW480 cell growth.
- Transcriptional activity of the TBE reporter construct was reduced by all lignans.
- Arctigenin demonstrated the most significant inhibition of Wnt/beta-catenin signaling.
- Arctigenin reduced beta-catenin levels through phosphorylation-induced degradation.
- Arctigenin decreased expression of Wnt/beta-catenin target genes and induced apoptosis.
Conclusions:
- Arctigenin potently inhibits human colon cancer cell growth by targeting the Wnt/beta-catenin signaling pathway.
- The methoxyl group in arctigenin may contribute to its potent inhibitory activity.
- Arctigenin represents a potential therapeutic agent for colon cancer prevention and treatment.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Inhibition of Cdk Activity